Anti-IL-6/IFNb2 Antibody (Olokizumab)
Catalog No.
F1396
Anti-IL-6/IFNb2 Antibody (Olokizumab)
Featured Products
Olokizumab (CDP 6038) is a humanized monoclonal antibody targeting interleukin-6 (IL-6). Olokizumab is used in the research of rheumatoid arthritis (RA).
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.94 kDa
Dry ice
1007223-17-7
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
CDP6038
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P05231
Human
Unconjugated
Monoclonal
Protein A
IgG4SP
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human IL-6 His at 2 ug/mL can bind Anti-IL-6/IFNb2 Antibody (Olokizumab)
IL-6 / IFNb2
Please avoid freeze-thaw cycles.